BNGO Key Statistics, Chart & Performance
The current stock price of BNGO is 1.58 USD. In the past month the price decreased by -1.25%. In the past year, price decreased by -78.33%.
BNGO Technical Analysis
BNGO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BNGO. BNGO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BNGO Financial Highlights
Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -20.56. The EPS increased by 77.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.81% | ||
| ROE | -77.49% | ||
| Debt/Equity | 0.07 |
BNGO Forecast & Estimates
9 analysts have analysed BNGO and the average price target is 7.65 USD. This implies a price increase of 384.18% is expected in the next year compared to the current price of 1.58.
For the next year, analysts expect an EPS growth of 92.31% and a revenue growth -2.24% for BNGO
BNGO Ownership
BNGO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 28.41 | 239.06B | ||
| DHR | DANAHER CORP | 31.39 | 170.97B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 195.4 | 59.38B | ||
| IQV | IQVIA HOLDINGS INC | 20.76 | 41.11B | ||
| A | AGILENT TECHNOLOGIES INC | 25.05 | 39.62B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.49 | 29.48B | ||
| WAT | WATERS CORP | 31.24 | 23.62B | ||
| ILMN | ILLUMINA INC | 34.97 | 23.30B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.09 | 18.36B | ||
| MEDP | MEDPACE HOLDINGS INC | 43.4 | 17.48B | ||
| RVTY | REVVITY INC | 24.33 | 13.21B | ||
| TEM | TEMPUS AI INC | N/A | 11.62B |
Related stock screener links
About BNGO
Company Profile
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Company Info
BIONANO GENOMICS INC
9540 Towne Centre Drive, Suite 100
San Diego CALIFORNIA 92121 US
CEO: R. Erik Holmlin
Employees: 98
Phone: 18588887600
BIONANO GENOMICS INC / BNGO FAQ
Can you describe the business of BIONANO GENOMICS INC?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 98 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Can you provide the latest stock price for BIONANO GENOMICS INC?
The current stock price of BNGO is 1.58 USD. The price increased by 9.72% in the last trading session.
What is the dividend status of BIONANO GENOMICS INC?
BNGO does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNGO stock?
BNGO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for BNGO stock?
9 analysts have analysed BNGO and the average price target is 7.65 USD. This implies a price increase of 384.18% is expected in the next year compared to the current price of 1.58.
Can you provide the sector and industry classification for BIONANO GENOMICS INC?
BIONANO GENOMICS INC (BNGO) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Is BIONANO GENOMICS INC (BNGO) expected to grow?
The Revenue of BIONANO GENOMICS INC (BNGO) is expected to decline by -2.24% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.